2026 Surgical Oncology Cancer Symposium

Memphis, TN US
November 14, 2026

The University of Tennessee Health Science Center Department of Surgery, Division of Surgical Oncology is hosting a one-day symposium on the management of soft tissue sarcoma (STS).  The purpose of this activity is to educate healthcare professionals on up-to-date strategies for the evaluation and management of patients with these musculoskeletal tumors.  The symposium will provide a unique opportunity for clinicians involved in the care of these patients to learn from and interact with leading national and local faculty to increase clinical knowledge, apply new data into practice, and ultimately improve patient outcomes.

Target Audience

  • Surgical Oncology
  • Orthopedic Oncology
  • Medical Oncology
  • Radiation Oncology
  • Pathology
  • Physicians
  • Advanced Practice Providers
  • Residents
  • Fellows
  • Medical Students

Professional Practice Gap 

This educational activity will provide physicians and healthcare providers with a needed overview and additional information related to the diagnosis and treatment options for soft tissue sarcoma.  They have limited familiarity with evolving molecular diagnostics, variation in multidisciplinary treatment sequencing, and knowledge gaps in radiation therapy indications.  There is an inconsistent management of rare and complex sarcoma presentations, as well as a need for improved multidisciplinary coordination and referral patterns.

Learning Objectives

  • Apply contemporary histopathologic and molecular diagnostic principles in the classification of soft tissue sarcomas to improve diagnostic accuracy, prognostication, and treatment selection.
  • Differentiate multidisciplinary treatment strategies for major sarcoma subtypes, including gastrointestinal stromal tumors (GIST), retroperitoneal sarcomas, and extremity soft tissue sarcomas, based on histology, stage, and disease location.
  • Evaluate the appropriate use of systemic therapy, surgery, and radiation therapy in the neoadjuvant, adjuvant, and metastatic settings for patients with soft tissue sarcoma.
  • Incorporate evidence-based surgical decision-making regarding limb-sparing approaches, multivisceral resection, margin optimization, and management of locally recurrent disease.
  • Integrate multidisciplinary case-based decision-making to optimize individualized treatment planning, functional outcomes, local control, and long-term survivorship in patients with sarcoma.
Course summary
Available credit: 
  • 4.75 AMA PRA Category 1 Credit™
  • 4.75 Attendance
Course opens: 
05/12/2026
Course expires: 
11/14/2026
Event starts: 
11/14/2026 - 7:30am CST
Event ends: 
11/14/2026 - 2:30pm CST
*** This live activity has been approved for up to 4.75 AMA PRA Category 1 CreditsTM****
2026 Surgical Oncology Cancer Symposium
Updates in the Multidisciplinary Management of Soft Tissue Sarcoma
 FedEx Event Center - Saturday, November 14, 2026 
TimeslotPresentationPresenter
7:30 - 7:50 AMContinental Breakfast 
7:50 - 8:00 AMWelcome and Conference Objectives:Paxton Dickson, MD
 Goals of Multidisciplinary Sarcoma CareConference Chair (Surgical Oncology)
 Overview of Conference Structure and Case-Based Discussions 
8:00 - 8:30 AMHistology, Molecular Pathology, and Genomics of Soft Tissue SarcomaKurt T. Patton, MD
8:30 - 9:00 AMMedical Oncology: Systemic Therapy for Soft Tissue SarcomaName?
9:00 - 9:30 AMCurrent Concepts in Radiation Therapy for Soft Tissue SarcomasArash O. Naghavi, MD, MS
9:30 - 9:45 AMQuestion and Answer 
9:45 - 10:00 AMBreak 
10:00 - 10:30 AMRetroperitoneal Sarcoma: Surgical & Multidisciplinary StrategiesChelsea Olson, MD
10:30 - 11:00 AMExtremity Sarcoma: Limb Salvage, Margins, and FunctionMichael Neel, MD
11:00 - 11:30 AMGastrointestinal Stromal Tumors (GIST): Multidisciplinary ManagementDavid Portnoy, MD & Ian Solsky, MD
11:30 - 11:45 AMQuestion and Answer 
11:45 - 12:45 PMLunch / Visit with Exhibitors 
12:45 - 1:15 PMConsiderations in the Management of Pediatric SarcomasAlberto Pappo, MD
1:15 - 2:30 PMMultidisciplinary Case-Based Panel - Surgical Oncology, Orthopedic Oncology, Medical Oncology, Radiation Oncology, PathologyPaxton Dickson, MD - Moderator
2:30 - 2:35 PMClosing Remarks and AdjournmentPaxton Dickson, MD
 Total CME4.75 hours (4 hours and 45 minutes)

 

FedEx Event Center at Shelby Farms Park
415 Great View Drive East
Memphis, TN 38134
United States

Parking

The FedEx Event Center at Shelby Farms Park offers ample, convenient, and free on-site parking.  The venue features dedicated parking spaces directly off Walnut Grove Road and adjacent to the building for each access to events.

AMA Credit Designation: The University of Tennessee College of Medicine (UTCOM) designates this live activity for a maximum of
4.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education for Non-Physicians: The UTCOM will issue Certificates of Participation to non-physicians for participating in this activity and designates it for CEUs using the national standard that 1 hour of educational instruction is awarded .1 CEU.
Accreditation: The UTCOM is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Available Credit

  • 4.75 AMA PRA Category 1 Credit™
  • 4.75 Attendance
Please login or register to take this course.

Space is limited.  There is no cost to attend this symposium.